This month, AI in medicine saw several important milestones: from FDA and CE approvals to landmark clinical studies. We’ve also included a deep dive on ambient AI scribes, combining industry updates with what clinicians themselves are saying about the tools they actually use. 💼 Earn for training the next generation of AI toolsPhysicians, Pathologists (Health Care and Social Assistance)Hourly contract · Remote · $100–$300 per hour Apply here☢Radiology & ImagingTranspara Breast AI improves sensitivity in cancer detection (Lancet Digital Health study)A new study in Lancet Digital Health found that Transpara, used as a second reader in mammography, increased breast cancer detection sensitivity by 8.4% versus the standard two‑radiologist double read — underscoring AI’s role in earlier diagnosis. Read moreUCSD segmentation AI reduces annotation needs by 20× (Nature Communications)UC San Diego researchers introduced an AI framework that generates synthetic image–mask pairs in a feedback loop. Published in Nature Communications, it trimmed labeled‑data needs by up to 20× while delivering 10–20% performance gains in medical image segmentation. Read moreFDA clears TechLive remote scanning platform (DeepHealth/RadNet)On August 7, the FDA granted 510(k) clearance to TechLive, enabling technologists to remotely operate MRI, CT, PET/CT, and ultrasound across sites. With 300+ scanners connected, it helps mitigate staffing shortages via real‑time remote supervision. Read more🧬Oncology & PathologyFDA grants De Novo authorization to ArteraAI ProstateArteraAI Prostate became the first AI tool authorized by the FDA for cancer prognosis. It analyzes digitized prostate biopsies with clinical data to predict aggressiveness and likely therapy benefit, setting a new category for AI‑driven digital pathology. Read moreCaris GPSai achieves 95% accuracy in tissue‑of‑origin study (Cancer Research Communications)Caris Life Sciences reported 95% accuracy for GPSai in identifying tumor tissue of origin, correcting some misdiagnoses. Trained on 200k+ whole‑exome/transcriptome profiles, it supports more confident treatment of cancers of unknown primary. Read more❤️CardiologyPMcardio integrates with Roche cobas® pulse for point‑of‑care AI ECGsPMcardio now integrates with Roche’s cobas® pulse point‑of‑care device, pairing AI ECG interpretation with bedside high‑sensitivity troponin testing. The CE‑marked setup enables faster, more accurate suspected‑MI triage. Read more👁️OphthalmologyZEISS PathFinder receives CE Mark for OCT‑based AI analysisIntegrated into the ZEISS CIRRUS OCT platform, PathFinder earned CE Mark approval. It flags abnormal macular scans and enhances OCT‑A image quality and layer segmentation to streamline retinal workflow. Read more🥓GastroenterologyColonoscopy AI boosts detection but shows deskilling risk (Lancet study)A randomized evaluation in The Lancet showed an AI polyp detector improved adenoma detection while active. After three months of reliance, endoscopists’ unassisted performance dipped when AI was off — suggesting potential deskilling without balanced training. Read more🦠Infectious DiseaseMEMORI earns MHRA and CE approval for infection predictionMEMORI analyzes live EHR signals to forecast hospital‑acquired infections up to 72 hours earlier than current methods. It received UK MHRA approval and EU Class IIb CE certification, enabling earlier intervention and capacity relief. Read more📝Deep Dive – Ambient AI ScribesSuki integrates with MEDITECH Expanse as first ambient AI note assistantSuki became the first ambient AI scribe natively embedded in MEDITECH’s Expanse EHR. Clinicians can capture encounters with notes automatically generated and inserted into the chart, reducing documentation burden and turnaround. Read moreWhat clinicians are saying (Reddit, August 2025):
Takeaway: Enterprise adoption is accelerating via deep EHR integrations, while many clinicians still favor nimble, affordable scribes that fit their daily workflows. |
Stay up-to-date with the latest AI tools for your medical practice
In partnership with September Update: AI Is Coming for Your Software — AI in Medicine Monthly 📰 AI Is Coming for Your Software Dozens of clinical AI tools launched, earned approvals, or published results after Aug 26 and through September. Below are the specialty updates with clear facts and links, followed by a quick roll-up of new software launches. ☢Radiology & Imaging GE HealthCare introduces AI-enabled Voluson Performance ultrasound systems with FDA clearance The Voluson Performance 18...
In partnership with From 1000+ Papers to a Lit Review in Minutes Stop wrestling with PubMed and black-box AI. Spine is the first iterative deep research tool that gives you control. Go from a query to a fully-sourced draft, then deepen your review with full transparency. Perfect for lit reviews, grant proposals, and analyzing new FDA rules. See how we did it. Get FDA LDT Report 🔎 PanDerm: AI Revolutionizes Dermatology with Multimodal Diagnosis 🔬 Breakthrough:PanDerm is a foundation vision...
🧠 Google Launches MedGemma for Healthcare App Developers 🔬 Breakthrough/Innovation Summary:Google has introduced MedGemma, a suite of open-source AI models designed to assist developers in building healthcare applications. Built on the Gemma 3 architecture, MedGemma includes a 4B multimodal model and a 27B text-only model, both optimized for medical text and image comprehension. 💡 Clinical/Business Impact:By offering fine-tunable and accessible models, MedGemma empowers developers to build AI...